In 2002, Congress investigated the panel and found that 97% of the people who are sit on it have conflicts with the pharmaceutical industry. And in fact, the congressional investigation cited one case where Four out of five members of the [vaccine recommendation] panel were working for Merck when they approved a vaccine for Merck. And one of the people on that panel who voted had a patent on that vaccine, which he then sold for $186 million. (01:25–01:34)
CLAIM
Asserts that a majority of a vaccine panel had ties to Merck during a vaccine approval.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
